Sept 12 (Reuters) - Merck (NYSE:MRK) Canada Inc:
* BRENZYS approved in Canada for treatment of adult patients with moderate to severe rheumatoid arthritis and ankylosing spondylitis Source text for Eikon: Further company coverage: MRK.N
Sept 12 (Reuters) - Merck (NYSE:MRK) Canada Inc:
* BRENZYS approved in Canada for treatment of adult patients with moderate to severe rheumatoid arthritis and ankylosing spondylitis Source text for Eikon: Further company coverage: MRK.N